Satsuma Pharmaceuticals
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 Oyster Point Blvd Ste 221, South San...Phone Number
(650) 410-3200Website
www.satsumarx.comRevenue
$7.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Satsuma Pharmaceuticals
Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to bringing novel treatments to people who suffer from migraine and other debilitating conditions. Satsuma Pharmaceuticals is a spinout company from the Japanese firm Shin Nippon Biomedical Laboratories (SNBL).Explore more
Satsuma Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Satsuma Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Satsuma Pharmaceuticals has new funding data
Check out if Satsuma Pharmaceuticals is spiking on competitors!
Product Launch: Get notified when Satsuma Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Satsuma Pharmaceuticals
Earning: See what the market has to say on Satsuma Pharmaceuticals recently announced quarterly report
Click to see if Satsuma Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Satsuma Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Satsuma Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Satsuma Pharmaceuticals
Compare insights from companies similar to Satsuma Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Satsuma Pharmaceuticals
$7.1M
11-50
Private
$80M
2016
SH
Shunji HarutaDirector & Chief Operating Officer
Company Profile Activity
Activity Insights
Satsuma Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Satsuma Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Satsuma Pharmaceuticals.
Satsuma Pharmaceuticals financials insights
Gather financial insights about Satsuma Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Share Placement
$80M
Satsuma Pharmaceuticals Tech Stack
A closer look at the technologies used by Satsuma Pharmaceuticals
Most Recent Scoops
Open Position
Mergers & Acquisitions (M&A)
Project
A mid-level source in Product Development has indicated that the organization is in the midst of initiatives related to quality assurance. Satsuma Pharmaceuticals is currently evaluating Qualio and MasterControl Quality Management System.
Quality Assurance, Product Development, Quality Management
Project
A mid-level source in Product Development has indicated that the organization is in the midst of initiatives related to project management software. Satsuma Pharmaceuticals is currently evaluating Smartsheet and Airtable.
Product Development, Enterprise Software, Software, Workforce Management
Pain Point
Project
Product Development, Product Management
Satsuma Pharmaceuticals News & Media
Satsuma Pharmaceuticals and SNBL Announce Publication of Impression of Use and Satisfaction with STS101 (Dihydroergotamine Nasal Powder (Atzumi™)) in Headache
Results show that participant impression through 12 months of treatment indicate STS101 is perceived as favorable across multiple attributes. Exploratory Efficacy Endpoints showed that STS101 provided rapid freedom from pain, from most bothersome symptoms at 2 hours and sustained...Satsuma Pharmaceuticals and SNBL Announce Four Abstracts to be Presented at the American Headache Society's 67th Annual Scientific Meeting
DURHAM, N.C., June 19, 2025 /PRNewswire/ -- Satsuma Pharmaceuticals, Inc., a late-stage biopharmaceutical company dedicated to bringing novel treatments to people who suffer from migraine and other debilitating conditions, and its corporate parent, Shin Nippon Biomedical Laboratories, Ltd....Migraine Market Enters New Era Following Satsuma Pharmaceuticals' ATZUMI and Amneal Pharmaceuticals' BREKIYA Regulatory Approval | DelveInsight
The approval of ATZUMI and BREKIYA is expected to significantly reshape the migraine market by introducing new, innovative treatment options. These therapies promise improved efficacy and convenience, potentially capturing a substantial share from existing CGRP inhibitors. Their entry may...Satsuma Pharmaceuticals Announces U.S. FDA Approval for Atzumi™ (Dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine
Atzumi™ (dihydroergotamine(DHE)) nasal powder is the first and only DHE nasal powder for the acute treatment of migraine with or without aura in adults in an easy-to-use, easy-to-carry device. Atzumi is the first and only product utilizing the SMART (Simple MucoAdhesive Release...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Satsuma Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to bringing novel treatments to people who suffer from migraine and other debilitating conditions. Satsuma Pharmaceuticals is a spinout company from the Japanese firm Shin Nippon Biomedical Laboratories (SNBL).... Read More
